This project assembles a unique set of brain specimens to test hypotheses on the relationship of inflammation to synaptic regression and neuron death during normal aging and Alzheimer disease (AD) pathogenesis using microarray technology. Because AD risk is driven by aging, we will evaluate normal brains across the adult life span to identify aging changes in gene expression, which may trigger feedforward cascades leading to irreversible neurodegeneration. To carry out this project a consortium of neuroscientists, neuropathologists and clinicians representing 6 ADCs has been assembled. Frozen, unfixed blocks (250 mg/sample) of the entorhinal cortex/subiculum (EC), hippocampus (HPC), superior frontal gyrus (SFG), and sensory-motor cortex (SMC) will be obtained primarily from five well-established NIA ADC brain banks. The tissue blocks will derive from neuropathologically normal controls, MCI, early mild-moderate AD, and terminal moderate-severe AD (N=10/group). PD cases with dementia but without significant AD pathology (N=10/group) will serve as a disease control. Assignment of cases to groups will be based on common ADC antemortem clinical criteria and postmortem neuropathologic criteria, particularly Braak staging. The experimental groups will be matched for gender and postmortem intervals, none of which will exceed 6 hours, a period during which our preliminary studies suggest that relatively little RNA degradation occurs. Total RNA will be characterized for size distribution and analyzed by Affymetrix gene arrays. Data will be stored in a dedicated hard-drive and searched for changes in specific pathways that may be early markers for and underlying causes of AD study. This proposal will focus on two hypotheses: 1). During aging and mild pathology select genes linked to synaptic function show compensatory changes in the initial stages of cognitive decline and these decline as degeneration evolves. 2). Brain inflammation is a key triggering mechanism resulting in conversion to MCI and/or AD and that inflammatory responses follow or precede synaptic change. Once an initial primary paper is published the overall data will be made available to the field via NACC for various investigators to analyze for the testing their own hypotheses.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG023173-01
Application #
6723376
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4 (O2))
Program Officer
Phelps, Creighton H
Project Start
2003-09-30
Project End
2008-08-31
Budget Start
2003-09-30
Budget End
2004-08-31
Support Year
1
Fiscal Year
2003
Total Cost
$494,325
Indirect Cost
Name
University of California Irvine
Department
Neurology
Type
Schools of Medicine
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Chou, Sh-Y; Shulman, J M; Keenan, B T et al. (2013) Genetic susceptibility for ischemic infarction and arteriolosclerosis based on neuropathologic evaluations. Cerebrovasc Dis 36:181-8
Shulman, Joshua M; Chen, Kewei; Keenan, Brendan T et al. (2013) Genetic susceptibility for Alzheimer disease neuritic plaque pathology. JAMA Neurol 70:1150-7
Berchtold, Nicole C; Coleman, Paul D; Cribbs, David H et al. (2013) Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease. Neurobiol Aging 34:1653-61
Cribbs, David H; Berchtold, Nicole C; Perreau, Victoria et al. (2012) Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study. J Neuroinflammation 9:179
De Jager, Philip L; Shulman, Joshua M; Chibnik, Lori B et al. (2012) A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol Aging 33:1017.e1-15
Chibnik, Lori B; Shulman, Joshua M; Leurgans, Sue E et al. (2011) CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol 69:560-9
Corneveaux, Jason J; Liang, Winnie S; Reiman, Eric M et al. (2010) Evidence for an association between KIBRA and late-onset Alzheimer's disease. Neurobiol Aging 31:901-9
Webster, Jennifer; Reiman, Eric M; Zismann, Victoria L et al. (2010) Whole genome association analysis shows that ACE is a risk factor for Alzheimer's disease and fails to replicate most candidates from Meta-analysis. Int J Mol Epidemiol Genet 1:19-30
Berchtold, Nicole C; Cribbs, David H; Coleman, Paul D et al. (2008) Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci U S A 105:15605-10
Parachikova, A; Agadjanyan, M G; Cribbs, D H et al. (2007) Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging 28:1821-33

Showing the most recent 10 out of 11 publications